{"url":"https://lda.senate.gov/api/v1/filings/6cdc1a67-82d1-4ff1-bcab-c79cf91d9bea/","filing_uuid":"6cdc1a67-82d1-4ff1-bcab-c79cf91d9bea","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2020,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/6cdc1a67-82d1-4ff1-bcab-c79cf91d9bea/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Aaron R. Lopez","dt_posted":"2020-07-19T18:57:46.760000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1300 Pennsylvania","registrant_address_2":"190-604","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401104260,"url":"https://lda.senate.gov/api/v1/registrants/401104260/","house_registrant_id":null,"name":"POLITICAL CAPITAL, LLC","description":"Government Affairs Firm","address_1":"1300 Pennsylvania","address_2":"190-604","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AARON LOPEZ","contact_telephone":"+1 202-753-7975","dt_updated":"2026-05-26T10:49:57.802218-04:00"},"client":{"id":201099,"url":"https://lda.senate.gov/api/v1/clients/201099/","client_id":12,"name":"MEDISCA INC","general_description":"Pharmaceutical Compounding Supplier","client_government_entity":false,"client_self_select":null,"state":null,"state_display":null,"country":"CA","country_display":"Canada","ppb_state":null,"ppb_state_display":null,"ppb_country":"CA","ppb_country_display":"Canada","effective_date":"2017-01-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Guidance documents, compounding pharmacy, appropriations language.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":123842,"prefix":"mr","prefix_display":"MR.","first_name":"AARON","nickname":null,"middle_name":"RAFAEL","last_name":"LOPEZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Guidance documents, compounding pharmacy, appropriations language.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":123842,"prefix":"mr","prefix_display":"MR.","first_name":"AARON","nickname":null,"middle_name":"RAFAEL","last_name":"LOPEZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}